Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Coagulation Factor X, also known as Stuart factor, is a vitamin K-dependent serine endopeptidase that plays a central role in the blood coagulation cascade. It is synthesized in the liver and circulates in plasma as an inactive zymogen. Activation to factor Xa occurs through both intrinsic and extrinsic pathways, leading to thrombin generation and fibrin clot formation. Deficiency can cause bleeding disorders, while its dysregulation is implicated in thrombotic conditions. Therapeutic interventions include Factor X concentrates to supplement deficient levels and anticoagulant drugs to inhibit its activity.
Factor X is activated to factor Xa, which then associates with cofactor Va to form the prothrombinase complex, converting prothrombin into thrombin, an essential step for fibrin clot formation. Some drugs directly or indirectly inhibit Factor Xa activity, preventing thrombin formation and subsequent clot formation. Factor X concentrates directly supplement Factor X levels, restoring the coagulation cascade.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coagulation Factor X (FX).